Christopher J. Alteri

Christopher J. Alteri

Auto-generated profile, based on publicly available information

Christopher J. Alteri

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MLM. Chelsea Lane
M. Chelsea Lane
CAChristopher J. Alteri
Christopher J. Alteri
SSSara N. Smith
Sara N. Smith
HMHarry Mobley
Harry Mobley
Uropathogenic Escherichia coli (UPEC) cause most uncomplicated urinary tract infections (UTIs) in humans. Because UTIs are considered to occur in an ascending manner, flagellum-mediated motility has been suggested to contribute to virulence by enabling UPEC to disseminate to the upper urinary tract. Previous studies from our laboratory and others have demonstrated a modest yet important role for flagella during ascending UTI. To better understand the role of flagella in vivo , we used biophotonic imaging to monitor UPEC infection and temporospatial flagellin gene expression during ascending UTI. Using em7-lux (constitutive) and fliC-lux transcriptional fusions, we show that flagellin expression by UPEC coincides with ascension of the ureters and colonization of the kidney. The patterns of fliC luminescence observed in vitro and in vivo were also validated by comparative quantitative PCR. Because fliC expression appeared coincident during ascension, we reassessed the contribution of fliC to ascending UTI using a low-dose intraurethral model of ascending UTI. Although wild-type UPEC were able to establish infection in the bladder and kidneys by 6 hours postinoculation, fliC mutant bacteria were able to colonize the bladder but were significantly attenuated in the kidneys at this early time point. By 48 hours postinoculation, the fliC mutant bacteria were attenuated in the bladder and kidneys and were not detectable in the spleen. These data provide compelling evidence that wild-type UPEC express flagellin and presumably utilize flagellum-mediated motility during UTI to ascend to the upper urinary tract and disseminate within the host.

29 May 2009 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CAChristopher J. Alteri
Christopher J. Alteri
SSSara N. Smith
Sara N. Smith
HMHarry Mobley
Harry Mobley
Microbial pathogenesis studies traditionally encompass dissection of virulence properties such as the bacterium's ability to elaborate toxins, adhere to and invade host cells, cause tissue damage, or otherwise disrupt normal host immune and cellular functions. In contrast, bacterial metabolism during infection has only been recently appreciated to contribute to persistence as much as their virulence properties. In this study, we used comparative proteomics to investigate the expression of uropathogenic Escherichia coli (UPEC) cytoplasmic proteins during growth in the urinary tract environment and systematic disruption of central metabolic pathways to better understand bacterial metabolism during infection. Using two-dimensional fluorescence difference in gel electrophoresis (2D-DIGE) and tandem mass spectrometry, it was found that UPEC differentially expresses 84 cytoplasmic proteins between growth in LB medium and growth in human urine (P<0.005). Proteins induced during growth in urine included those involved in the import of short peptides and enzymes required for the transport and catabolism of sialic acid, gluconate, and the pentose sugars xylose and arabinose. Proteins required for the biosynthesis of arginine and serine along with the enzyme agmatinase that is used to produce the polyamine putrescine were also up-regulated in urine. To complement these data, we constructed mutants in these genes and created mutants defective in each central metabolic pathway and tested the relative fitness of these UPEC mutants in vivo in an infection model. Import of peptides, gluconeogenesis, and the tricarboxylic acid cycle are required for E. coli fitness during urinary tract infection while glycolysis, both the non-oxidative and oxidative branches of the pentose phosphate pathway, and the Entner-Doudoroff pathway were dispensable in vivo. These findings suggest that peptides and amino acids are the primary carbon source for E. coli during infection of the urinary tract. Because anaplerosis, or using central pathways to replenish metabolic intermediates, is required for UPEC fitness in vivo, we propose that central metabolic pathways of bacteria could be considered critical components of virulence for pathogenic microbes. Bacteria that cause infections often have genes known as virulence factors that are required for bacteria to cause disease. Studying virulence factors such as toxins, adhesins, and secretion and iron-acquisition systems is a fundamental part of understanding infectious disease mechanisms. In contrast, little is known about the contribution of bacterial metabolism to infectious disease. This study shows that E. coli, which cause most urinary tract infections, utilize peptides as a preferred carbon source in vivo and requires some, but not all, of the central metabolic pathways to infect the urinary tract. Specifically, pathways that can be used to replenish metabolites, known as anaplerotic reactions, are important for uropathogenic E. coli infections. These findings help explain how metabolism can contribute to the ability of bacteria to cause a common infection.

20 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CAChristopher J. Alteri
Christopher J. Alteri
JXJuan Xicohténcatl-Cortes
Juan Xicohténcatl-Cortes
SHSonja Hess
Sonja Hess
GCGuillermo Caballero-Olín
Guillermo Caballero-Olín
JGJorge A. Girón
Jorge A. Girón
RFRichard L. Friedman
Richard L. Friedman
Mycobacterium tuberculosisis responsible for nearly 3 million human deaths worldwide every year. Understanding the mechanisms and bacterial factors responsible for the ability ofM. tuberculosisto cause disease in humans is critical for the development of improved treatment strategies. Many bacterial pathogens use pili as adherence factors to colonize the host. We discovered thatM. tuberculosisproduces fine (2- to 3-nm-wide), aggregative, flexible pili that are recognized by IgG antibodies contained in sera obtained from patients with active tuberculosis, indicating that the bacilli produce pili or pili-associated antigen during human infection. PurifiedM. tuberculosispili (MTP) are composed of low-molecular-weight protein subunits encoded by the predictedM. tuberculosisH37Rv ORF, designated Rv3312A. MTP bind to the extracellular matrix protein lamininin vitro, suggesting that MTP possess adhesive properties. Isogenicmtpmutants lost the ability to produce Mtpin vitroand demonstrated decreased laminin-binding capabilities. MTP shares morphological, biochemical, and functional properties attributed to bacterial pili, especially with curli amyloid fibers. Thus, we propose that MTP are previously unidentified host-colonization factors ofM. tuberculosis.

1 February 2012 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
CAChristopher J Alteri
Christopher J Alteri
HMHarry Mobley
Harry Mobley

4 November 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SKSho Kitamoto
Sho Kitamoto
CAChristopher J. Alteri
Christopher J. Alteri
MRMichael Rodrigues
Michael Rodrigues
HNHiroko Nagao-Kitamoto
Hiroko Nagao-Kitamoto
KSKohei Sugihara
Kohei Sugihara
NKNobuhiko Kamada
Nobuhiko Kamada

18 September 2009 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CAChristopher J. Alteri
Christopher J. Alteri
EHErin C. Hagan
Erin C. Hagan
KSKelsey E. Sivick
Kelsey E. Sivick
SSSara N. Smith
Sara N. Smith
HMHarry Mobley
Harry Mobley
Uncomplicated infections of the urinary tract, caused by uropathogenic Escherichia coli, are among the most common diseases requiring medical intervention. A preventive vaccine to reduce the morbidity and fiscal burden these infections have upon the healthcare system would be beneficial. Here, we describe the results of a large-scale selection process that incorporates bioinformatic, genomic, transcriptomic, and proteomic screens to identify six vaccine candidates from the 5379 predicted proteins encoded by uropathogenic E. coli strain CFT073. The vaccine candidates, ChuA, Hma, Iha, IreA, IroN, and IutA, all belong to a functional class of molecules that is involved in iron acquisition, a process critical for pathogenesis in all microbes. Intranasal immunization of CBA/J mice with these outer membrane iron receptors elicited a systemic and mucosal immune response that included the production of antigen-specific IgM, IgG, and IgA antibodies. The cellular response to vaccination was characterized by the induction and secretion of IFN-γ and IL-17. Of the six potential vaccine candidates, IreA, Hma, and IutA provided significant protection from experimental infection. In immunized animals, class-switching from IgM to IgG and production of antigen-specific IgA in the urine represent immunological correlates of protection from E. coli bladder colonization. These findings are an important first step toward the development of a subunit vaccine to prevent urinary tract infections and demonstrate how targeting an entire class of molecules that are collectively required for pathogenesis may represent a fundamental strategy to combat infections. Because urinary tract infections (UTIs) are a significant healthcare burden, it would be beneficial to develop a vaccine to prevent uncomplicated UTI caused by Escherichia coli. Using a large-scale screening process we uniformly identified proteins involved in iron uptake as potential vaccine candidates against E. coli. Iron acquisition is a critical function required by bacteria in order to cause infections. In uropathogenic Escherichia coli, this function is mediated by a repertoire of systems that scavenge iron from the host during infection. We found that vaccination with certain iron receptors from these systems is sufficient to elicit protective immunity from experimental urinary tract infection. Induction of an antibody response played a key role in protection from infection because antibody class-switching and the production of antibodies in urine correlated with reduced numbers of bacteria in the bladder. By targeting an entire class of molecules involved in iron acquisition instead of a single protein, it was possible to successfully identify components of a protective UTI vaccine. This strategy could be a useful approach in the development of vaccines to prevent infections caused by other pathogenic bacteria.